KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Retained Earnings (2016 - 2025)

Pacira BioSciences has reported Retained Earnings over the past 16 years, most recently at -$199.3 million for Q4 2025.

  • Quarterly results put Retained Earnings at -$199.3 million for Q4 2025, down 58211.37% from a year ago — trailing twelve months through Dec 2025 was -$199.3 million (down 58211.37% YoY), and the annual figure for FY2025 was -$199.3 million, down 58211.37%.
  • Retained Earnings for Q4 2025 was -$199.3 million at Pacira BioSciences, down from $4.1 million in the prior quarter.
  • Over the last five years, Retained Earnings for PCRX hit a ceiling of $4.1 million in Q3 2025 and a floor of -$243.5 million in Q1 2021.
  • Median Retained Earnings over the past 5 years was -$91500.0 (2023), compared with a mean of -$46.1 million.
  • Biggest five-year swings in Retained Earnings: plummeted 2223870.0% in 2024 and later soared 3768.57% in 2025.
  • Pacira BioSciences' Retained Earnings stood at $167000.0 in 2021, then tumbled by 327.54% to -$380000.0 in 2022, then skyrocketed by 165.0% to $247000.0 in 2023, then soared by 38.87% to $343000.0 in 2024, then tumbled by 58211.37% to -$199.3 million in 2025.
  • The last three reported values for Retained Earnings were -$199.3 million (Q4 2025), $4.1 million (Q3 2025), and $4.1 million (Q2 2025) per Business Quant data.